Planning to submit NDA under accelerated approval pathway in H2 2025 based on existing clinical data, including results from BEACON and AURORA Phase 2 trials Achieved regulatory alignment on APOLLO ..
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback